Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-FR
Language English French
Date Updated 2021-04-01 2021-03-25
Drug Identification Number 02380048 02380048
Brand name TOVIAZ TOVIAZ
Common or Proper name Toviaz Toviaz
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients FESOTERODINE FUMARATE FESOTERODINE FUMARATE
Strength(s) 8MG 8MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30's 30's
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-03-19 2021-03-19
Actual start date
Estimated end date 2021-04-01 2021-04-01
Actual end date 2021-03-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited available inventory is on allocation until depletion on approx March 19th. Limited available inventory is on allocation until depletion on approx March 19th.
Health Canada comments